Citigroup Inc Maravai Lifesciences Holdings, Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Citigroup Inc holds 116,696 shares of MRVI stock, worth $490,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,696
Previous 110,610
5.5%
Holding current value
$490,123
Previous $919,000
30.9%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MRVI
# of Institutions
201Shares Held
139MCall Options Held
250KPut Options Held
22.8K-
Gtcr LLC20.2MShares$84.6 Million10.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$49.6 Million0.0% of portfolio
-
12 West Capital Management LP New York, NY11.6MShares$48.7 Million6.99% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$40.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$35.1 Million2.55% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $552M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...